Mannose-conjugated chitosan nanoparticles loaded with rifampicin for the treatment of visceral leishmaniasis

Abdel-Magid, 1996, Reductive amination of aldehydes and ketones with sodium triacetoxyborohydride studies on direct and indirect reductive amination procedures, Journal of Organic Chemistry, 61, 3849, 10.1021/jo960057x

Bakker-Woudenberg, 1995, Delivery of antimicrobials to infected tissue macrophages, Advanced Drug Delivery Reviews, 17, 5, 10.1016/0169-409X(95)00037-8

Busilacchi, 2013, Chitosan stabilizes platelet growth factors and modulates stem cell differentiation toward tissue regeneration, Carbohydrate polymers, 98, 665, 10.1016/j.carbpol.2013.06.044

Calvo, 1997, Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers, Journal of Applied Polymer Science, 63, 125, 10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO;2-4

Chellat, 2005, Therapeutic potential of nanoparticulate systems for macrophage targeting, Biomaterials, 26, 7260, 10.1016/j.biomaterials.2005.05.044

Chono, 2007, Uptake characteristics of liposomes by rat alveolar macrophages: Influence of particle size and surface mannose modification, Journal of Pharmacy and Pharmacology, 59, 75, 10.1211/jpp.59.1.0010

Davis, 1997, Biomedical applications of nanotechnology-implications for drug targeting and gene therapy, Trends in Biotechnology, 15, 217, 10.1016/S0167-7799(97)01036-6

Duncan, 2003, The dawning era of polymer therapeutics, Nature Reviews Drug Discovery, 2, 347, 10.1038/nrd1088

Ferrari, 1999, A coat protein on phagosomes involved in the intracellular survival of mycobacteria, Cell, 14, 435, 10.1016/S0092-8674(00)80754-0

Ghosh, 1982, Targeting of liposomes towards different cell types of rat liver through the involvement of liposomal surface glycosides, Archives of Biochemistry and Biophysics, 213, 266, 10.1016/0003-9861(82)90461-1

Gribble, 1975, Selective reduction of aldehydes with sodium triacetoxyborohydride, Journal of the Chemical Society, Chemical Communications, 535, 10.1039/c39750000535

Guellec, 1997, Stability of rifampicin in plasma: consequences for therapeutic monitoring and pharmacokinetic studies, Therapeutic Drug Monitoring, 19, 669, 10.1097/00007691-199712000-00011

Gulyaev, 1999, Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles, Pharmaceutical Research, 16, 1564, 10.1023/A:1018983904537

Jain, 2008, Mannosylated gelatin nanoparticles bearing an anti-HIV drug didanosine for site-specific delivery, Nanomedicine: NBM, 4, 41, 10.1016/j.nano.2007.11.004

Jiang, 2008, The potential of mannosylated chitosan microspheres to target macrophage mannose receptors in an adjuvant-delivery system for intranasal immunization, Biomaterials, 29, 1931, 10.1016/j.biomaterials.2007.12.025

Karki, 2009, Formulation and evaluation of coencapsulated rifampicin and isoniazid liposomes using different lipids, Acta Pharmaceutica Sciencia, 51, 177

Liang, 1996, Oligonucleotide targeting to alveolar macrophages by mannose receptor-mediated endocytosis, Biochimica et Biophysica Acta, 1279, 227, 10.1016/0005-2736(95)00237-5

Marty, 2002, Treatment of visceral leishmaniasis: a review of current treatment practices, Expert Opinion on Pharmacotherapy, 3, 1101, 10.1517/14656566.3.8.1101

Murray, 2004, Treatment of visceral leishmaniasis in 2004, The American Journal of Tropical Medicine and Hygiene, 71, 787, 10.4269/ajtmh.2004.71.787

Muzzarelli, 2010, Chitins and chitosans as immunoadjuvants and non-allergenic drug carriers, Marine Drugs, 8, 292, 10.3390/md8020292

Neuber, 2008, Leishmaniasis, Journal der Deutschen Dermatologischen Gesellschaft, 9, 754, 10.1111/j.1610-0387.2008.06809.x

Reddy, 2004, Pharmacokinetics and biodistribution studies of doxorubicin loaded poly(butyl cyanoacrylate) nanoparticles synthesized by two different techniques, Biomedical Papers, 148, 161, 10.5507/bp.2004.029

Rinaudo, 2006, Chitin and chitosan: Properties and applications, Progress in Polymer Science, 31, 603, 10.1016/j.progpolymsci.2006.06.001

Sakuma, 1990, Binding constants of metal cations to and Hamaker constant for poly (NN-lysine diylterephthaloyl) microcapsules, Journal of Colloid and Interface Science, 135, 455, 10.1016/0021-9797(90)90016-H

Seferian, 2001, Immune stimulating activity of two new chitosan containing adjuvant formulation, Vaccine, 19, 661, 10.1016/S0264-410X(00)00248-6

Tiwari, 2011, Macrophage specific targeting of isoniazid through mannosylated gelatin microspheres, AAPS PharmSciTech, 12, 900, 10.1208/s12249-011-9654-6

Torres-Lugo, 2002, Physicochemical behavior and cytotoxic effects of p(methacrylic acid-g-ethylene glycol) nanospheres for oral delivery of proteins, Journal of Controlled Release, 80, 197, 10.1016/S0168-3659(02)00027-5

Vandervoort, 2004, Preparation and evaluation of drug-loaded gelatin nanoparticles for topical ophthalmic use, European Journal of Pharmaceutics and Biopharmaceutics, 57, 251, 10.1016/S0939-6411(03)00187-5

Wadhwa, 2003, Receptor mediated glycotargeting, Journal of Drug Targeting, 11, 255, 10.1080/10611860310001636557

Wijagkanalan, 2008, Efficient targeting to alveolar macrophages by intratracheal administration of mannosylated liposomes in rats, Journal of Controlled Release, 125, 121, 10.1016/j.jconrel.2007.10.011

Wisse, 1984, Structural elements determining transport and exchange process in the liver, 1

Yalpani, 1984, Some chemical and analytical aspects of polysaccharide modifications 3. Formation of branch-chain, soluble chitosan derivatives, Macromolecules, 17, 272, 10.1021/ma00133a003

Yeeprae, 2006, Effect of mannose density on mannose receptor-mediated cellular uptake of mannosylated o/w emulsions by macrophages, Journal of Controlled Release, 114, 193, 10.1016/j.jconrel.2006.04.010

Zhou, 2007, Controlled release of PEI/DNA complexes from mannose-bearing chitosan microspheres as a potent delivery system to enhance immune response to HBV DNA vaccine, Journal of Controlled Release, 121, 200, 10.1016/j.jconrel.2007.05.018